This study tested the safety and effectiveness of a new drug (study drug) in treating the worsening of COPD symptoms.
The study drug aimed to decrease inflammation in the lungs of people with COPD, which could reduce episodes of COPD symptoms worsening (called exacerbations or flare-ups) and improve health-related quality of life.
End date: 10th April 2026
Link to study on clinicaltrials.gov